Conflict Escalates Between Pharma, Bank
A fracas between a bank and a pharmaceutical firm has prompted two multimillion-dollar lawsuits and a Chapter 11 filing for the drug company's two U.S. subsidiaries....To view the full article, register now.
Already a subscriber? Click here to view full article